104480 — TK Chemical Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩147bn
- KR₩436bn
- KR₩416bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 9,164 | 16,512 | 24,408 | 28,571 | 17,185 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 83,963 | 48,407 | 70,416 | 64,132 | 33,402 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 213,904 | 190,237 | 254,654 | 222,564 | 156,978 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 161,534 | 148,144 | 110,942 | 72,854 | 72,239 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 680,222 | 678,929 | 1,148,739 | 1,431,445 | 1,372,243 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 311,011 | 289,881 | 323,525 | 339,232 | 343,518 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 408,540 | 411,702 | 480,901 | 483,515 | 422,880 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 271,682 | 267,227 | 667,838 | 947,930 | 949,363 |
Total Liabilities & Shareholders' Equity | 680,222 | 678,929 | 1,148,739 | 1,431,445 | 1,372,243 |
Total Common Shares Outstanding |